Presentations will be delivered by experts from a wide variety of leading research groups including Pfizer, GSK, and Bio-Techne, along with co-hosts IPA, ACROBiosystems, and Curia. SALT LAKE CITY, ...

South Korea-based biotech firms 1ST Biotherapeutics and LigaChem Biosciences (Kosdaq: 141080) have entered a strategic ...

Single and multi-dose studies of the small molecule TREM2 agonist VG-3927 clear early safety hurdle. Meanwhile, new findings ...

BenevolentAI has entered a two-year agreement with the MRC Technology to investigate new small molecule and antibody drug candidates. The UK-based artificial intelligence company has teamed up ...

Expanded collaboration leverages complementary expertise to unlock next-generation oncology therapeuticsFocus on breakthrough ADC payloads and immuno-oncology candidates with out-licensing potential ...

and Skyhawk Therapeutics for small-molecule drugs that affect protein expression from RNA. The flurry of deals comes as Roche is facing biosimilar competition for its ‘big three’ antibodies ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...

A clinical-stage biotech company developing bifunctional small-molecule therapeutics designed to eliminate disease-driving ...

Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...